Skip to content

Labcorp Holdings LH Current Debt

Current Debt at other companies

Quest Diagnostics logo
Quest DiagnosticsDGX
$10M-98.0%
NeoGenomics logo
NeoGenomicsNEO
$1.7M
Charles River Laboratories logo
Charles River LaboratoriesCRL
$6.7M+5,436%
Exagen Inc. logo
Exagen Inc.XGN
$580K-77.1%
Castle Biosciences logo
Castle BiosciencesCSTL
$1.67M+50.0%
IQVIA logo
IQVIAIQV
$2.29B+74.7%

Other financials

Income statement

See full
Revenue$3.7B+5.8%
Gross profit$1.1B+6.3%
Operating income$451.6M+14.5%
Net income$298.7M+25.6%
EPS (diluted)$3.64+28.2%

Balance sheet

See full
Cash & equivalents$141.8M-78.1%
Total debt$6.8B+11.8%
Total equity$8.6B+1.6%
Total assets$18.5B+2.6%

Cash flow

See full
Operating cash flow$445.5M-28.2%
CapEx$121.0M-4.0%
Free cash flow$313.9M-42.2%

Valuation

See full
Market cap$25.77B+18.8%
Enterprise value$32.39B+19.5%
P/E25.7×-2.7×
P/S1.8×+0.2×

Profitability

See full
Gross margin28.9%+0.7pp
Operating margin10.4%+1.6pp
Net margin7%+1.3pp
FCF margin8.1%-1.3pp

Returns & leverage

See full
Return on equity11.7%+2.5pp
Debt / equity0.8×+0.1×
Current ratio1.8×+0.3×

Where this comes from

Reported directly by Labcorp Holdings in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtCurrent.

The official record: Labcorp Holdings’s 8-K, filed July 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Labcorp Holdings's current debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Labcorp Holdings's current debt?
Labcorp Holdings (LH) reported current debt of $900K in Q2 2026.
How has Labcorp Holdings's current debt changed year-over-year?
Labcorp Holdings's current debt decreased by 79.1% year-over-year, from $4.3M to $900K.
What is the long-term trend for Labcorp Holdings's current debt?
Over 5 years (2020 to 2025), Labcorp Holdings's current debt has grown at a 136.9% compound annual growth rate (CAGR), from $6.7M to $500.1M.
What does current debt mean?
The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.